Role of colonic microbiota in colorectal carcinogenesis: a systematic review.

BACKGROUND AND AIM The human colonic mucosa is populated by a wide range of microorganisms, usually in a symbiotic relation with the host. Sometimes this balance is lost and a state of dysbiosis arises, exposing the colon to different metabolic and inflammatory stimuli (according to the microbiota's changing profile). Recent findings lead to hypothesize that this unbalance may create a subclinical pro-inflammatory state that increases DNA mutations and, therefore, colorectal carcinogenesis. In this article we aim to systematically review the scientific evidence regarding colonic microbiota and its role in colorectal carcinogenesis. METHODS Systematic review of PubMed searching results for original articles studying microbiota and colorectal cancer until November 2014. RESULTS Thirty-one original articles studied the role of colon microbiota in colorectal carcinoma including both human and animal studies. Different and heterogeneous methods were used and different bacteria were considered. Nevertheless, some bacteria are consistently augmented (such as Fusobacteria, Alistipes, Porphyromonadaceae, Coriobacteridae, Staphylococcaceae, Akkermansia spp. and Methanobacteriales), while other are constantly diminished in colorectal cancer (such as Bifidobacterium, Lactobacillus, Ruminococcus, Faecalibacterium spp., Roseburia, and Treponema). Moreover, bacteria metabolites amino acids are increased and butyrate is decreased throughout colonic carcinogenesis. CONCLUSION Conclusive evidence shows that colorectal carcinogenesis is associated with microbial dysbiosis. This information may be used to create new prophylactic, diagnostic and therapeutic strategies for colorectal cancer.

[1]  A. Mira,et al.  Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers , 2015, Journal of Gastroenterology.

[2]  K. Søreide,et al.  Cellular metabolism in colorectal carcinogenesis: Influence of lifestyle, gut microbiome and metabolic pathways. , 2015, Cancer letters.

[3]  E. Platz,et al.  The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  P. Schloss,et al.  The Human Gut Microbiome as a Screening Tool for Colorectal Cancer , 2014, Cancer Prevention Research.

[5]  Anthony A. Fodor,et al.  Microbial genomic analysis reveals the essential role of inflammation in bacteria-induced colorectal cancer , 2014, Nature Communications.

[6]  M. Silverberg,et al.  Analyzing the Human Microbiome: A “How To” guide for Physicians , 2014, The American Journal of Gastroenterology.

[7]  Patrick D Schloss,et al.  Structure of the gut microbiome following colonization with human feces determines colonic tumor burden , 2014, Microbiome.

[8]  Alberto Martin,et al.  The multifaceted role of the intestinal microbiota in colon cancer. , 2014, Molecular cell.

[9]  Cynthia L Sears,et al.  Microbes, microbiota, and colon cancer. , 2014, Cell host & microbe.

[10]  Yongzhi Yang,et al.  Analysis of the Intestinal Lumen Microbiota in an Animal Model of Colorectal Cancer , 2014, PloS one.

[11]  Y. Iwakura,et al.  Alterations in the microbiota drive interleukin-17C production from intestinal epithelial cells to promote tumorigenesis. , 2014, Immunity.

[12]  Huidong Shi,et al.  Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. , 2014, Immunity.

[13]  Edward W. Lee,et al.  Microbiome Analysis of Stool Samples from African Americans with Colon Polyps , 2013, PloS one.

[14]  Emmanuel Buc,et al.  Colonization of the Human Gut by E. coli and Colorectal Cancer Risk , 2013, Clinical Cancer Research.

[15]  J. Petrosino,et al.  The Gut Microbiome Modulates Colon Tumorigenesis , 2013, mBio.

[16]  J. Gilbert,et al.  Adenomatous polyps are driven by microbe-instigated focal inflammation and are controlled by IL-10-producing T cells. , 2013, Cancer research.

[17]  P. Bork,et al.  Richness of human gut microbiome correlates with metabolic markers , 2013, Nature.

[18]  R. Bresalier,et al.  The Microbiome and Colorectal Neoplasia: Environmental Modifiers of Dysbiosis , 2013, Current Gastroenterology Reports.

[19]  M. Meyerson,et al.  Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. , 2013, Cell host & microbe.

[20]  Amy M. Sheflin,et al.  Stool Microbiome and Metabolome Differences between Colorectal Cancer Patients and Healthy Adults , 2013, PloS one.

[21]  G. Gao,et al.  Dysbiosis Signature of Fecal Microbiota in Colorectal Cancer Patients , 2013, Microbial Ecology.

[22]  E. Elinav,et al.  Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer , 2013, Proceedings of the National Academy of Sciences.

[23]  Tomas Hrncir,et al.  Altered Gut Microbiota Promotes Colitis-Associated Cancer in IL-1 Receptor–Associated Kinase M–Deficient Mice , 2013, Inflammatory bowel diseases.

[24]  K. Kinzler,et al.  Cancer Genome Landscapes , 2013, Science.

[25]  D. Pezet,et al.  High Prevalence of Mucosa-Associated E. coli Producing Cyclomodulin and Genotoxin in Colon Cancer , 2013, PloS one.

[26]  R. Sandler,et al.  Fusobacterium Is Associated with Colorectal Adenomas , 2013, PloS one.

[27]  S. Pettersson,et al.  Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APCMin/+ mice. , 2012, Carcinogenesis.

[28]  A. Leite-Moreira,et al.  Decreased Toll-interacting protein and peroxisome proliferator-activated receptor γ are associated with increased expression of Toll-like receptors in colon carcinogenesis , 2012, Journal of Clinical Pathology.

[29]  S. Dowd,et al.  SMAD4 haploinsufficiency associates with augmented colonic inflammation in select humans and mice. , 2011, Annals of clinical and laboratory science.

[30]  Liping Zhao,et al.  Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers , 2011, The ISME Journal.

[31]  A. Watson,et al.  Colon Cancer: A Civilization Disorder , 2011, Digestive Diseases.

[32]  Louis Vermeulen,et al.  Microenvironmental regulation of stem cells in intestinal homeostasis and cancer , 2011, Nature.

[33]  N. Hall,et al.  Towards the Human Colorectal Cancer Microbiome , 2011, PloS one.

[34]  J. Tap,et al.  Microbial Dysbiosis in Colorectal Cancer (CRC) Patients , 2011, PloS one.

[35]  P. Brigidi,et al.  Human intestinal microbiota: cross-talk with the host and its potential role in colorectal cancer , 2011, Critical reviews in microbiology.

[36]  Zaid Abdo,et al.  Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas , 2010, Gut microbes.

[37]  M. Arends,et al.  DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndrome , 2010, Histopathology.

[38]  H. Herfarth,et al.  Modulation of the Intestinal Microbiota Alters Colitis-Associated Colorectal Cancer Susceptibility , 2009, PloS one.

[39]  E. Holmes,et al.  Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. , 2008, Environmental microbiology.

[40]  R. Knight,et al.  The Human Microbiome Project , 2007, Nature.

[41]  Y. Atomi,et al.  Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation. , 2007, Cancer research.

[42]  A. Rustgi,et al.  The genetics of hereditary colon cancer. , 2007, Genes & development.

[43]  H. Huhtinen,et al.  Qualitative and quantitative analyses of the bifidobacterial microbiota in the colonic mucosa of patients with colorectal cancer, diverticulitis and inflammatory bowel disease. , 2007, World journal of gastroenterology.

[44]  R. B. Jackson,et al.  Toward an ecological classification of soil bacteria. , 2007, Ecology.

[45]  M. Pop,et al.  Metagenomic Analysis of the Human Distal Gut Microbiome , 2006, Science.

[46]  P. Peltomäki.  Role of DNA mismatch repair defects in the pathogenesis of human cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  Margaret Robertson,et al.  Identification and characterization of the familial adenomatous polyposis coli gene , 1991, Cell.

[48]  张静,et al.  Banana Ovate family protein MaOFP1 and MADS-box protein MuMADS1 antagonistically regulated banana fruit ripening , 2015 .

[49]  A. Leite-Moreira,et al.  Functional polymorphisms of Toll-like receptors 2 and 4 alter the risk for colorectal carcinoma in Europeans. , 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[50]  R. Dumitrescu,et al.  Nutrigenomics: implications for breast and colon cancer prevention. , 2012, Methods in molecular biology.

[51]  C. Mettlin,et al.  Diet and colon cancer. , 1979, American journal of epidemiology.